Kylin Therapeutics' Unattributed Round

Kylin Therapeutics raised a round of funding on March 06, 2009.

Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatment of many common diseases inc…

Articles about Kylin Therapeutics' Unattributed Round: